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doi:10.1016/j.joca.2011.12.017Osteoarthritis (OA) is a prevalent multifactorial disease which
increases with age and following injury; it is primarily character-
ised by degeneration of articular cartilage and results in joint stiff-
ness and pain. Animal models have been used to understand the
pathophysiology of the disease and identify potential treatment
targets. However, not all targets identiﬁed with in vivo models
have proven relevant for treating human disease1. Many questions
also remain unanswered, with regards for example to cartilage
repair, themechanisms involved in pain or matrix-degrading prote-
ases regulation. A plethora of animalmodels, which differ in etiopa-
thology and severity have been developed but there is no ‘gold
standard’ that encompasses every aspect of OA. Joint instability
can be induced by surgical or chemical techniques in a number of
animal species including rats, mice, guinea pigs, rabbits, dogs and
sheep. Spontaneous models also exist and more recently geneti-
cally modiﬁed mouse models have been used2.
The OA community has been working together to improve the
utility of animal models with efforts focused in two directions:
harmonisation of experimental methods and outcomes, and critical
assessment of the in vivo models. The OARSI histopathology initia-
tive, which started a decade ago, aims to standardise the scoring
systems used in the evaluation of the OA disease process3, in order
to make results between different studies comparable. Other initia-
tives have attempted to characterise in vivo models of OA and link
models to disease mechanisms; two relatively recent initiatives
have been led by the Canadian Arthritis Network in collaboration
with OsteoArthritis Research Society International (OARSI)4, and
Arthritis Research UK5.
A common goal of these projects is to improve the efﬁciency of
research in the OA ﬁeld and their success crucially depends on the
transparency in the methods and conduct of animal experiments.
Comprehensive reporting is essential to enable models to be char-
acterised and experimental outcomes to be standardised. However,
as shown in a survey of over 270 studies covering a wide range of
experimental ﬁelds, carried out by the UK National Centre for the
Replacement, Reﬁnement and Reduction of animals in research
(NC3Rs), many aspects of an animal experiment are not included
in publications6. This compromises the peer review process, limits
the interpretation that can be drawn from a study, and preventsResearch Society International. Pupeers from replicating and building on the ﬁndings. To improve
the reporting of animal research, the NC3Rs has developed the
ARRIVE (Animal Research, Reporting of In Vivo Experiments) guide-
lines7 (www.nc3rs.org.uk/ARRIVE). The guidelines consist of a 20
items checklist of the key information that should be included in
a manuscript to ensure that a study can be reviewed, scrutinised
and reproduced.
Speciﬁcally, the guidelines recommend including sufﬁcient
scientiﬁc background to understand the motivation and context
for the study and a clear description of the objective. They include
a detailed description of the study design including steps taken to
minimise subjective bias, such as randomisation of the animals
into experimental groups and concealment of treatment while
assessing the outcome. Failure to include such steps in a study
can compromise the validity of the results, as recently demon-
strated in a systematic review looking the effectiveness of potential
treatments in animalmodels of multiple sclerosis. Non-randomised
studies were found to report signiﬁcantly higher efﬁcacy than rand-
omised studies. Similarly, studies which did not blind the assess-
ment of outcome reported higher estimates of efﬁcacy than
blinded studies8.
The ARRIVE guidelines also recommend a comprehensive
description of the experimental procedures and animal characteris-
tics and housing. These details are extremely relevant for animal
models of OA as disease development or severity often depends on
animal characteristics such as gender, age or strain. For example, in
a murine model using surgical destabilisation of the medial
meniscus to induce the disease, severity has been shown to depend
on sex and wild-type strain, as male hormones were shown to exac-
erbate OA9 and the 129SvEv strainwas associatedwith amore severe
formof the disease10. Considering that age is a risk factor for humans,
it is perhaps not surprising that 12-month-old mice developed more
severe OA lesions and expressed transcriptional differences in their
joints compared to 12-week-old mice11, crucially however this high-
lights the importance of reporting such animal characteristics to
ensure that results are comparable between studies.
Experimental procedures should specify how, when, where the
experiment was carried out and why it was carried out that way.
Particularly relevant for models using surgical techniques, thisblished by Elsevier Ltd. All rights reserved.
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thesia and analgesia protocol. Pain is an inherent part of human
OA and murine models provide a system to elucidate the mecha-
nisms responsible for OA pain and to identify potential treatments
(e.g., Ref. 12). It is however important to consider that both sex and
strain have been identiﬁed as confounding factors in the pain
response, both in nociception and anti-nociception13.
Additionally, the type of anaesthetic or post-surgical analgesic
used may inﬂuence OA-induced pain. All these variables should
therefore be available in the publication, as scientiﬁc peers will
need this information to interpret the results and the implications
of the study.
The ARRIVE guidelines also include reference to describing the
housing and husbandry conditions, which may seem like a lot of
information to report in a publication, but seemingly irrelevant
features such as the number of cage companions, beddingmaterials,
environmental enrichment or food composition have the potential
to inﬂuence the outcome of OA experiments. For example, group
housing has been shown to inﬂuence many physiological markers
and alkaline phosphatase, a marker of osteoblast activity14, is low-
ered in animals that are housed in groups15. In Sprague Dawley
rats, the type of bedding can modulate levels of antioxidants such
as ascorbic acid and glutathione16, both of which have a role in
human OA17. In addition, different types of environmental enrich-
ment devices, from plastic tubes to running wheels, have been
shown to inﬂuence the severity of OA bymodifying the activity level
of mice18,19. Finally, both the type of food and the access to food are
important variables to include in publications reporting experi-
ments on OA models as this is linked to obesity, a well recognised
risk factor in human OA. High-fat diet has been shown to induce
knee OA in mice19 and there is evidence that providing laboratory
rodents with continuous access to food leads to obesity20.
Finally, the guidelinesprovide recommendationsonhow to report
experimental results, including adverse effects and details about the
statistical analysis. They also include suggestions about what should
be reported in the discussion, such as the study limitations, the scien-
tiﬁc implications andhow theﬁndings of the studyare likely to trans-
late to other species and their relevance to humans. These
recommendations are not new toOsteoarthritis and Cartilage readers
as the journal already advocates such reporting standards, which
have been the subject of several recent editorials21,22. The journal’s
decision to endorse the ARRIVE guidelines and republish them in
this issue sends a strong signal in terms of the quality of animal
research expected in OA. Comprehensive and transparent reporting
will in turn facilitate the task of harmonising and mapping the path-
ogenesis of OA models, to ensure that preclinical research translate
into successful treatment strategies in humans.
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